Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2011-07-26
2011-07-26
Saoud, Christine J (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S017400, C514S018300, C530S300000
Reexamination Certificate
active
07985736
ABSTRACT:
The present invention relates to compositions to treat CaV2 disorders. The invention also relates to methods treating CaV2 disorders. The invention further relates to kits for treating CaV2 disorders in a subject. The invention further relates to methods of identifying novel treatments for treating Cav2 disorders in a subject.
REFERENCES:
patent: 4389404 (1983-06-01), Zhorov et al.
patent: 5429921 (1995-07-01), Harpold et al.
patent: 5792846 (1998-08-01), Harpold et al.
patent: 6846823 (2005-01-01), Landau et al.
patent: 7410950 (2008-08-01), Garry et al.
Wells, J.A. (1990). Additivity of mutational effects in proteins. Biochemistry. 29(37):8509-8517.
Ngo et al. (1994). Computational complexity, protein structure prediction, and the Levinthal paradox. In Merz and Le Grand (Eds.) the Protein Folding Problem and Tertiary Structure Prediction. Birkhauser:Boston, pp. 491-495.
Malmberg et al. (1995). Pain, 60:83-90.
Agler Heather L.
Yue David T.
Corless Peter F.
Edwards Angell Palmer & & Dodge LLP
Hunter-Ensor, Esq. Melissa
Lockard Jon M
Saoud Christine J
LandOfFree
High throughput screen utilizing newly discovered... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with High throughput screen utilizing newly discovered..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and High throughput screen utilizing newly discovered... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2661552